Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical CBD for Thumb Basal Joint Arthritis
NCT04611347Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Jul 2020
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Zygel in osteoarthritis of the thumb carpometacarpal joint (2 arms), sponsored by University of Virginia. Primary endpoints: Change in Hand Strength at 2 weeks, Change in the PROMIS Upper Extremity Tests at 2 weeks and 2 more. Started Jul 2020; status: completed.
02
Drugs
Zygel
03
Conditions
osteoarthritis of the thumb carpometacarpal joint
Beyond the preview
Go deeper on NCT04611347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04611347.